65 related articles for article (PubMed ID: 21465167)
1. Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.
Villaronga MA; López-Mateo I; Markert L; Espinosa E; Fresno Vara JA; Belandia B
Breast Cancer Res Treat; 2011 Aug; 128(3):891-8. PubMed ID: 21465167
[TBL] [Abstract][Full Text] [Related]
2. Identification of BAF57 mutations in human breast cancer cell lines.
Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
[TBL] [Abstract][Full Text] [Related]
3. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.
García-Pedrero JM; Kiskinis E; Parker MG; Belandia B
J Biol Chem; 2006 Aug; 281(32):22656-64. PubMed ID: 16769725
[TBL] [Abstract][Full Text] [Related]
4. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.
Harte MT; O'Brien GJ; Ryan NM; Gorski JJ; Savage KI; Crawford NT; Mullan PB; Harkin DP
Cancer Res; 2010 Mar; 70(6):2538-47. PubMed ID: 20215511
[TBL] [Abstract][Full Text] [Related]
5. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
[TBL] [Abstract][Full Text] [Related]
6. N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.
Kazantseva A; Sepp M; Kazantseva J; Sadam H; Pruunsild P; Timmusk T; Neuman T; Palm K
J Neurochem; 2009 May; 109(3):807-18. PubMed ID: 19245665
[TBL] [Abstract][Full Text] [Related]
7. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
8. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
[TBL] [Abstract][Full Text] [Related]
9. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57.
Chen J; Archer TK
Mol Cell Biol; 2005 Oct; 25(20):9016-27. PubMed ID: 16199878
[TBL] [Abstract][Full Text] [Related]
10. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
[TBL] [Abstract][Full Text] [Related]
11. Aberrant BAF57 signaling facilitates prometastatic phenotypes.
Balasubramaniam S; Comstock CE; Ertel A; Jeong KW; Stallcup MR; Addya S; McCue PA; Ostrander WF; Augello MA; Knudsen KE
Clin Cancer Res; 2013 May; 19(10):2657-67. PubMed ID: 23493350
[TBL] [Abstract][Full Text] [Related]
12. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.
Link KA; Burd CJ; Williams E; Marshall T; Rosson G; Henry E; Weissman B; Knudsen KE
Mol Cell Biol; 2005 Mar; 25(6):2200-15. PubMed ID: 15743818
[TBL] [Abstract][Full Text] [Related]
13. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
15. Mutation of GATA3 in human breast tumors.
Usary J; Llaca V; Karaca G; Presswala S; Karaca M; He X; Langerød A; Kåresen R; Oh DS; Dressler LG; Lønning PE; Strausberg RL; Chanock S; Børresen-Dale AL; Perou CM
Oncogene; 2004 Oct; 23(46):7669-78. PubMed ID: 15361840
[TBL] [Abstract][Full Text] [Related]
16. Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines.
Abbondanza C; De Rosa C; D'Arcangelo A; Pacifico M; Spizuoco C; Piluso G; Di Zazzo E; Gazzerro P; Medici N; Moncharmont B; Puca GA
J Cell Physiol; 2012 Mar; 227(3):964-75. PubMed ID: 21503890
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.
Chi TH; Wan M; Zhao K; Taniuchi I; Chen L; Littman DR; Crabtree GR
Nature; 2002 Jul; 418(6894):195-9. PubMed ID: 12110891
[TBL] [Abstract][Full Text] [Related]
18. The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex.
Lomelí H; Castillo-Robles J
FEBS Lett; 2016 Jun; 590(11):1555-69. PubMed ID: 27149204
[TBL] [Abstract][Full Text] [Related]
19. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
Kim Y; Kim H; Jang SW; Ko J
Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]